Biotron (ASX:BIT) Share Price and News

Market Cap (19-Sep) $5,403,732 (1,096th)	Close (30-Jun) $0.026 0 (0%)	Volume (30-Jun) 3,174,615	Shortsold (20-Nov) 421,583 (0.03%) (497th)
52w High $0.005	52w Low $0.002	P/E 11.92	EPS 0

	Subject
	BIT BIT Ann: Second Site Approved for Phase 2 Covid-19 Trial
	1 (current) 2 3
	BIT BIT Ann: Commencement Phase 2 Covid-19 Clinical Trial
	BIT BIT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	BIT BIT Ann: Cleansing Notice
	BIT BIT Ann: Application for quotation of securities - BIT
	BIT BIT Ann: Completion of Phase 2 HIV-1 Clinical Trials
	BIT BIT Ann: International Presentation of BIT225 COVID-19 Data
	BIT BIT Ann: Half Yearly Report and Accounts
	BIT BIT Ann: Notification of cessation of securities - BIT
	BIT BIT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	BIT BIT Ann: CLEANSING NOTICE
	BIT BIT Ann: Application for quotation of securities - BIT
	BIT BIT Ann: Change of Director's Interest Notice
	BIT BIT Ann: Notification of cessation of securities - BIT
	BIT BIT Ann: Cleansing Notice
	BIT BIT Ann: Listed Options Information
	BIT BIT Ann: Application for quotation of securities
	BIT BIT Ann: Application for quotation of securities - BIT
	BIT BIT Ann: Proposed issue of securities - BIT
	BIT BIT Ann: Rights Issue Closed
	BIT BIT Ann: Supplementary Prospectus
	BIT BIT Ann: Cancel - Proposed issue of securities - BIT
	BIT BIT Ann: Appendix 3B
	BIT BIT Ann: $1.43M R&D rebate received
	BIT BIT Ann: Results of Annual General Meeting
	BIT BIT Ann: Chairman's Address and Presentation to AGM
	BIT BIT Ann: Presentation to Investors
	BIT BIT Ann: Clarification of Fractional Entitlements
	BIT BIT Ann: Commencement of Rights Trading - BITRC
	BIT BIT Ann: Letter to Shareholders
	BIT BIT Ann: Prospectus
	BIT BIT Ann: Renounceable Issue
	BIT BIT Ann: Proposed issue of securities - BIT
	BIT BIT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	BIT BIT Ann: Annual Report and Notice of Annual General Meeting
	BIT BIT Ann: Second BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited
	BIT BIT Ann: Bit225 Covid-19 Human Study Commenced
	BIT BIT Ann: BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited
	BIT BIT Ann: Appendix 4G and Corporate Governance Statement
	BIT BIT Ann: Full Year Statutory Accounts and Appendix 4E
	BIT BIT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	BIT BIT Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM
	BIT BIT Ann: BIT225 EFFECTIVE AGAINST ESTABLISHED SARS-CoV-2 IN ANIMALS
	BIT BIT Ann: Quarterly Cash Flow Report Appendix 4C
	BIT BIT Ann: Quarterly Activities Report
	BIT BIT Ann: $1.56M R&D Rebate Received
	BIT BIT Ann: BIT225 Effectiveness Against COVID-19 in Animals
	BIT BIT Ann: Half Yearly Report and Accounts
	BIT BIT Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	BIT BIT Ann: Quarterly Appendix 4C Cash Flow Report

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Mesoblast

MSB

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
18-Sep	$0.00	307,000	0.00 (0.00%)
12-Sep	$0.00	759,440	+0.00 (16.67%)
11-Sep	$0.00	4,540,250	0.00 (0.00%)
05-Sep	$0.00	226,580	0.00 (0.00%)
04-Sep	$0.00	50,000	0.00 (0.00%)
03-Sep	$0.00	50,000	0.00 (14.29%)
29-Aug	$0.00	289,631	0.00 (12.50%)
28-Aug	$0.00	230,470	0.00 (0.00%)
22-Aug	$0.00	370,771	+0.00 (33.33%)
21-Aug	$0.00	100,000	0.00 (0.00%)
15-Aug	$0.00	2,877,600	0.00 (25.00%)
14-Aug	$0.00	17,826,417	+0.00 (60.00%)
07-Aug	$0.00	479,090	0.00 (0.00%)
31-Jul	$0.00	200,000	+0.00 (25.00%)
30-Jul	$0.00	913,399	0.00 (20.00%)
4 up, 4 down, and 7 flat days

High $0.03	Low $0.03	Trades 35	Turnover $84,085	Volume 3,174,615
30 June 2023 at 3:42pm

High $0.03	Low $0.03	Trades 35	Turnover $84,085	Volume 3,174,615
30 June 2023 at 3:42pm

Biotron Health Care

$0.026 (0%)

$0.026 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices